Showing results (71-80 of 89) with videos related to
Sort By:
Pageof 9
Cancer Research|August 24, 2018
Epigenetic Reprogramming with Antisense Oligonucleotides Enhances the Effectiveness of Androgen Receptor Inhibition in Castration-Resistant Prostate CancerLanbo Xiao, Jean C Tien, Josh Vo, et al.Molecular Cancer|October 12, 2019
LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinomaYan Xu, Yuan Li, Jiankang Jin, et al.Journal of Medicinal Chemistry|June 24, 2008
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitorNancy Zhou, Oscar Moradei, Stephane Raeppel, et al.Molecular Cancer Therapeutics|April 17, 2008
MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivoMarielle Fournel, Claire Bonfils, Yu Hou, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 18, 2016
Plasmin Prevents Dystrophic Calcification After Muscle InjuryNicholas A Mignemi, Masato Yuasa, Courtney E Baker, et al.Bioorganic & Medicinal Chemistry Letters|January 22, 2008
4-(Heteroarylaminomethyl)-N-(2-aminophenyl)-benzamides and their analogs as a novel class of histone deacetylase inhibitorsSylvie Fréchette, Silvana Leit, Soon Hyung Woo, et al.Bioorganic & Medicinal Chemistry Letters|February 13, 2009
N-(3-fluoro-4-(2-arylthieno[3,2-b]pyridin-7-yloxy)phenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: a novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitorsStéphane Raeppel, Stephen Claridge, Oscar Saavedra, et al.Bioorganic & Medicinal Chemistry Letters|October 27, 2009
N-(4-(6,7-Disubstituted-quinolin-4-yloxy)-3-fluorophenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: a novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitorsMichael Mannion, Stéphane Raeppel, Stephen Claridge, et al.Cancer Communications (London, England)|April 10, 2026
Proliferation and Apoptosis Adaptor Protein 15 (PEA15), a Potential Oncogenic Regulator of VHL and HIF1A Identified through Proteomic Analysis in Hepatocellular CarcinomaYun Seong Jeong, Ji-Hyun Shin, Soo Mi Kim, et al.Nature|June 10, 2016
Image-based detection and targeting of therapy resistance in pancreatic adenocarcinomaRaymond G Fox, Nikki K Lytle, Dawn V Jaquish, et al.Pageof 9